Sayyed Omar Gilani, MD | |
2071 Herndon Ave, Clovis, CA 93611-6101 | |
(559) 324-5100 | |
Not Available |
Full Name | Sayyed Omar Gilani |
---|---|
Gender | Male |
Speciality | Pain Medicine - Pain Medicine |
Location | 2071 Herndon Ave, Clovis, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093246662 | NPI | - | NPPES |
Entity Name | Permanente Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Over the next 18 months, psychiatrists will revise the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, which is used to determine how U.S. residents' mental health is assessed, diagnosed and treated, the Los Angeles Times reports.
Roche announced today that the cobas KRAS Mutation Test is now commercially available in Europe for use in colorectal cancer.
Over the past decade various pieces of the puzzle how signal transmission controls immunity have been coming together.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD), announced today that results from the Phase III EINSTEIN-Extension (EXT) clinical trial of the novel oral anticoagulant rivaroxaban showed a significant reduction in the risk of recurrent symptomatic venous thromboembolism (VTE), compared to placebo, in patients who have been treated for a previous deep vein thrombosis (DVT) or pulmonary embolism (PE).
Researchers have demonstrated that an antibiotic is effective at treating acute asthma attacks, potentially providing a new way to help asthma sufferers.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Sayyed Omar Gilani, MD 2071 Herndon Ave, Clovis, CA 93611-6101 Ph: (559) 324-5100 | Sayyed Omar Gilani, MD 2071 Herndon Ave, Clovis, CA 93611-6101 Ph: (559) 324-5100 |
News Archive
Over the next 18 months, psychiatrists will revise the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, which is used to determine how U.S. residents' mental health is assessed, diagnosed and treated, the Los Angeles Times reports.
Roche announced today that the cobas KRAS Mutation Test is now commercially available in Europe for use in colorectal cancer.
Over the past decade various pieces of the puzzle how signal transmission controls immunity have been coming together.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD), announced today that results from the Phase III EINSTEIN-Extension (EXT) clinical trial of the novel oral anticoagulant rivaroxaban showed a significant reduction in the risk of recurrent symptomatic venous thromboembolism (VTE), compared to placebo, in patients who have been treated for a previous deep vein thrombosis (DVT) or pulmonary embolism (PE).
Researchers have demonstrated that an antibiotic is effective at treating acute asthma attacks, potentially providing a new way to help asthma sufferers.
› Verified 3 days ago